indazoles has been researched along with warfarin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Karaczyn, A; Keppler, BK; Kozłowski, H; Trynda-Lemiesz, L | 1 |
| Boehm, HJ; Boehringer, M; Bur, D; Gmuender, H; Huber, W; Klaus, W; Kostrewa, D; Kuehne, H; Luebbers, T; Meunier-Keller, N; Mueller, F | 1 |
| Burton, B; Primeaux, B; Shuey, S | 1 |
| Angapelly, S; Angeli, A; Arifuddin, M; Sri Ramya, PV; Supuran, CT | 1 |
| Fukuda, R; Gotoh, N; Hashida, M; Hashida, Y; Murakami, T; Suda, K; Tsujikawa, A; Yoshimura, N | 1 |
| Adachi, H; Ito, A; Kawasaki, Y; Kikuchi, M; Mano, N; Takasaki, S | 1 |
| Kabir, MZ; Kandandapani, S; Mohamad, SB; Ridzwan, NFW; Tayyab, S | 1 |
7 other study(ies) available for indazoles and warfarin
| Article | Year |
|---|---|
Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III).
Topics: Bilirubin; Chromatography; Circular Dichroism; Dextrans; Heme; Humans; Indazoles; Models, Chemical; Organometallic Compounds; Protein Binding; Protein Conformation; Serum Albumin; Spectrometry, Fluorescence; Spectrophotometry; Ultraviolet Rays; Warfarin | 2000 |
Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.
Topics: Anti-Infective Agents; Coumarins; Crystallography, X-Ray; DNA Topoisomerases, Type II; Enzyme Inhibitors; Indazoles; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Novobiocin; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance; Topoisomerase II Inhibitors; Ultracentrifugation | 2000 |
Supratherapeutic INR resulting from the initiation of warfarin in a patient receiving axitinib.
Topics: Aged; Angiogenesis Inhibitors; Anticoagulants; Axitinib; Binding, Competitive; Drug Interactions; Humans; Imidazoles; Indazoles; International Normalized Ratio; Male; Protein Binding; Warfarin | 2018 |
Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
Topics: Amides; Binding Sites; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Catalytic Domain; Coumarins; Humans; Indazoles; Inhibitory Concentration 50; Isoenzymes; Molecular Dynamics Simulation; Neoplasms; Structure-Activity Relationship | 2017 |
High-density lipoprotein mutant eye drops for the treatment of posterior eye diseases.
Topics: Angiogenesis Inhibitors; Animals; Apolipoprotein A-I; Cell-Penetrating Peptides; Choroidal Neovascularization; Coumarins; Drug Carriers; Indazoles; Lipoproteins, HDL; Liposomes; Male; Mice, Inbred C57BL; Mutation; Nanoparticles; Ophthalmic Solutions; Pyrimidines; Sulfonamides; Thiazoles | 2017 |
Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report.
Topics: Administration, Oral; Aged; Carcinoma, Renal Cell; Drug Interactions; Drug Monitoring; Humans; Indazoles; Kidney Neoplasms; Male; Pyrimidines; Sulfonamides; Warfarin | 2020 |
Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.
Topics: Antineoplastic Agents; Binding Sites; Circular Dichroism; Diazepam; Humans; Indazoles; Molecular Docking Simulation; Phenylbutazone; Protein Binding; Protein Kinase Inhibitors; Pyrimidines; Serum Albumin, Human; Spectrometry, Fluorescence; Sulfonamides; Thermodynamics; Warfarin | 2022 |